ASSOCIATION ANALYSIS OF PIOGLITAZONE EFFECTIVENESS IN TREATMENT OF NAFLD PATIENTS WITH OBESITY AND PPARG RS1801282 (PRO12ALA) GENOTYPE.

Objective: The aim: To study the association between the effectiveness of treatment with pioglitazone non-alcoholic fatty liver disease (NAFLD) in patients with obesity and PPARG rs1801282 (Pro12Ala)-polymorphism in Ukrainians.

Patients And Methods: Materials and methods: 123 patients with NAFLD in combination with obesity 1, 2, 3 classes were included in comprehensive weight loss program (5 visits, 12-weeks). The case group was treated with pioglitazone 15 mg / day, while the control group received only program.

[STUDY OF SENSITIVITY TO ANTI-MICROBIAL AGENTS OF MICRO-ORGANISMS FROM ZONE OF PURULENT INFLAMMATION AMONG PATIENTS OF MAXILLOFACIAL HOSPITAL DEPARTMENT].

The importance of control for nosocomial and community-acquired infections is one of the priorities of practical surgery, and maxillofacial surgery is no exception in this matter. Aim of study - to determine the spectrum of antimicrobial activity of widespread antiseptics and antibacterial agents used for topical treatment of odontogenic phlegmons of the maxillofacial region. A bacteriological study of purulent wound exudate was carried out for 109 patients of the maxillofacial hospital department with a diagnosis of odontogenic phlegmons.